Stone Warren — SEC Form 4 filings
SEC reporting owner CIK 1955295. 18 Form 4 filings on record with FilingPulse; latest filed 2026-08-25.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-02-27 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 5,700 shares, $48,895 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 22,128 shares, $276,682 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 47.
- Largest priced transaction: sale of 22,128 shares @ $12.50 ($276,682) in NEOGENOMICS INC, filed 2026-01-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEOGENOMICS INC (NEO) | Pres & Chief Operating Officer | 18 | 1 leg · 5,700 sh · $48,895 | 1 leg · 22,128 sh · $276,682 | 47 |
Form 4 filings — Stone Warren
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 28,106 @ $0 · Tax withholding (F): 11,060 @ $0 · Option exercise (M): 28,106 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 5,830 @ $0 · Tax withholding (F): 3,783 @ $0 · Option exercise (M): 5,830 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 5,969 @ $0 · Tax withholding (F): 2,349 @ $0 · Option exercise (M): 5,969 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 17,562 @ $0 · Tax withholding (F): 6,911 @ $0 · Option exercise (M): 17,562 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 253,378 (derivative) @ $0 · Grant/award (A): 152,594 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 28,105 @ $0 · Tax withholding (F): 7,142 @ $0 · Option exercise (M): 8,443 @ $0 · Tax withholding (F): 3,323 @ $0 · Option exercise (M): 28,105 (derivative) @ $0 · Option exercise (M): 8,443 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | NEOGENOMICS INC (NEO) | Sale (S): 22,128 @ $12.50 | EDGAR |
| 2026-01-15 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 59,382 @ $0 · Tax withholding (F): 15,127 @ $0 | EDGAR |
| 2025-12-03 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 8,776 @ $0 | EDGAR |
| 2025-05-13 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 9,613 @ $0 · Tax withholding (F): 2,341 @ $0 · Purchase (P): 5,700 @ $8.58 · Option exercise (M): 9,613 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 5,969 @ $0 · Tax withholding (F): 1,454 @ $0 | EDGAR |
| 2025-04-03 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 94,518 (derivative) @ $0 · Grant/award (A): 52,687 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 8,443 @ $0 · Tax withholding (F): 2,472 @ $0 · Grant/award (A): 143,266 (derivative) @ $0 · Grant/award (A): 84,317 (derivative) @ $0 · Option exercise (M): 8,443 (derivative) @ $0 | EDGAR |
| 2025-01-16 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 59,382 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | NEOGENOMICS INC (NEO) | Tax withholding (F): 6,224 @ $0 | EDGAR |
| 2024-05-14 | 4 | NEOGENOMICS INC (NEO) | Option exercise (M): 9,612 @ $0 · Tax withholding (F): 2,341 @ $14.86 · Option exercise (M): 9,612 @ $0 · Option exercise (M): 9,612 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 29,976 (derivative) @ $0 · Grant/award (A): 17,908 (derivative) @ $0 · Grant/award (A): 17,908 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | NEOGENOMICS INC (NEO) | Grant/award (A): 42,344 (derivative) @ $0 · Grant/award (A): 25,329 (derivative) @ $0 · Grant/award (A): 25,330 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1955295 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →